GENNEX exchange filings, corporate actions and results
4 Sep 2026
⚑ Filing
Gennex Laboratories Ltd - 531739 - Intimation Of Book Closure For The Purpose Of 41St AGM Of Gennex Laboratories LimitedBSE filing · raw filing ↗
4 Sep 2026
⚑ Filing
Gennex Laboratories Ltd - 531739 - Board Meeting Outcome for Meeting Held On September 04, 2026BSE filing · raw filing ↗
27 Aug 2026
⚑ Filing
Gennex Laboratories Ltd - 531739 - Board Meeting Intimation for For Fixing Date, Time And Venue Of 41St AGM Of The CompanyBSE filing · raw filing ↗
17 Aug 2026
⚑ Filing
Gennex Laboratories Ltd - 531739 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE filing · raw filing ↗
14 Aug 2026
⚑ Result
Gennex Laboratories Ltd - 531739 - Un-Audited Financial Results For The Quarter Ended June 30, 2026BSE filing · raw filing ↗
14 Aug 2026
⚑ Result
Q1 FY27 results filed — revenue ₹40 Cr (+16.6% YoY), PAT ₹5 Cr (−7.0% YoY)BSE filing · raw filing ↗
10 Jun 2026
⚑ Filing
Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.BSE filing · raw filing ↗
10 Jun 2026
⚑ Filing
Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.BSE filing · raw filing ↗
10 Jun 2026
⚑ Filing
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.BSE filing · raw filing ↗
10 Jun 2026
⚑ Filing
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.BSE filing · raw filing ↗
NOT BUILT YETPer-item summaries & sentiment — not built yetOne-line plain-language summaries and a sentiment read of every filing. Not built yet. When they exist they will describe — never advise.
Official filings & corporate actions · newest first
